Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03423485
NA

Safety and Performance of the CG-100 in Patients Undergoing Colorectal Surgery.

Sponsor: Colospan Ltd.

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the CG-100 device, a single use, temporary intraluminal bypass device,intended to reduce contact of fecal content with an anastomotic site, following colorectal surgery (open or laparoscopic)

Official title: A Prospective, Multi-center, Single-arm, Open-label Study Designed to Evaluate Safety and Performance Profile of the CG-100 Intraluminal Bypass Device in Patients Undergoing Colorectal Surgery

Key Details

Gender

All

Age Range

22 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2018-01-01

Completion Date

2018-12-15

Last Updated

2026-07-06

Healthy Volunteers

No

Interventions

DEVICE

CG-100 Intraluminal Bypass Device

Intended to reduce contact of fecal content with an anastomotic site , following colorectal surgery.

Locations (5)

Hospital Beaujon

Paris, Clichy, France

University Hospital of Hamburg

Hamburg, Germany

Soroka Medical Center

Beersheba, Israel

Carmel Medical Center

Haifa, Israel

CHUV, University Hospital Vaudois

Lausanne, Switzerland